DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

UBS Maintains Neutral on Amgen, Raises Price Target to $238

UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.

Benzinga · 01/22/2020 13:49

UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.